MicroRNA Profiling of Adrenocortical Tumors Reveals miR-483 as a Marker of MalignancyPATTERSON, Erin E; HOLLOWAY, Alisha K; JULIE WENG et al.Cancer. 2011, Vol 117, Num 8, pp 1630-1639, issn 0008-543X, 10 p.Article

The prevalence and prognostic value of BRAF mutation in thyroid cancer. DiscuissionKEBEBEW, Electron; JULIE WENG; BAUER, Juergen et al.Annals of surgery. 2007, Vol 246, Num 3, pp 466-471, issn 0003-4932, 6 p.Conference Paper

Clinical and Molecular Features of Papillary Thyroid Cancer in Adolescents and Young AdultsVRIENS, Menno R; MOSES, Willieford; JULIE WENG et al.Cancer. 2011, Vol 117, Num 2, pp 259-267, issn 0008-543X, 9 p.Article

Inhibition of SRC Corrects GM-CSF Hypersensitivity That Underlies Juvenile Myelomonocytic LeukemiaBUNDA, Severa; KANG, Michelle W; SYBINGCO, Stephanie S et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 8, pp 2540-2550, issn 0008-5472, 11 p.Article

Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF^V600E positive papillary thyroid cancers. DiscussionRUAN, Daniel T; WARREN, Robert S; JULIE WENG et al.Surgery. 2008, Vol 144, Num 6, pp 908-914, issn 0039-6060, 7 p.Article